Kupffer cells inhibition prevents hepatic lipid peroxidation and damage induced by carbon tetrachloride

被引:60
|
作者
Muriel, P
Alba, N
Pérez-Alvarez, VM
Shibayama, M
Tsutsumi, VK
机构
[1] Inst Politecn Nacl, CINVESTAV, Secc Externa Farmacol, Mexico City 07000, DF, Mexico
[2] Inst Politecn Nacl, CINVESTAV, Dept Expt Pathol, Mexico City 07000, DF, Mexico
关键词
gadolinium chloride; cytokines; liver injury; free radicals; glycogen; CCl4;
D O I
10.1016/S1532-0456(01)00237-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this work was to determine if the action mechanism of gadolinium on CCl4-induced liver damage is by preventing lipid peroxidation (that may be induced by Kupffer cells) and its effects on liver carbohydrate metabolism. Four groups of rats were treated with CCl4, CCl4 + GdCl3, GdCl3, and vehicles. CCl4 was given orally (0.4 g 100 g(-1) body wt.) and GdCl3 (0.20 g 100 g(-1) body wt.) was administered i.p. All the animals were killed 24 h after treatment With CCl4 or vehicle. Glycogen and lipid peroxidation were measured in liver. Alkaline phosphatase, gamma -glutamyl transpeptidase, alanine amino transferase activities and bilirubins were measured in rat serum. A liver histological analysis was performed. CO, induced significant elevations on enzyme activities and bilirubins; GdCl3 completely prevented this effect. Liver lipid peroxidation increased 2.5-fold by CCl4 treatment; this effect was also prevented by GdCl3. Glycogen stores were depleted by acute intoxication with CCl4. However, GdCl3 did not prevent this effect. The present study shows that Kupffer cells may be responsible for liver damage induced by carbon tetrachloride and that lipid peroxidation is produced or stimulated by Kupffer cells, since their inhibition with GdCl3 prevented both lipid peroxidation and CCl4-induced liver injury. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [1] Inhibition or Kupffer cells by gadolinium chloride prevents acute liver damage induced by CCl4 probably by preventing lipid peroxidation.
    Muriel, P
    Perez-Alvarez, VM
    Shibayama, M
    Tsutsumi, VK
    HEPATOLOGY, 2001, 34 (04) : 282A - 282A
  • [2] HEPATIC-MICROSOMAL LIPID DAMAGE INDUCED BY CARBON-TETRACHLORIDE
    JAMES, JL
    SMUCKLER, EA
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 612 - 612
  • [3] Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis
    Aleynik, SI
    Leo, MA
    Ma, XL
    Aleynik, MK
    Lieber, CS
    JOURNAL OF HEPATOLOGY, 1997, 27 (03) : 554 - 561
  • [4] HEPATIC LIPID PEROXIDATION IN ACUTE FATAL HUMAN CARBON TETRACHLORIDE POISONING
    HASHIMOTO, S
    GLENDE, EA
    RECKNAGEL, RO
    NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (20): : 1082 - +
  • [5] Dose-response relationships for lipid peroxidation, DNA damage and inhibition of intercellular communication by carbon tetrachloride
    Chipman, JK
    Beddowes, EJ
    Cowles, C
    TOXICOLOGY, 2001, 164 (1-3) : 192 - 192
  • [6] Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis
    Miyazaki, T
    Karube, M
    Matsuzaki, Y
    Ikegami, T
    Doy, M
    Tanaka, N
    Bouscarel, B
    JOURNAL OF HEPATOLOGY, 2005, 43 (01) : 117 - 125
  • [8] 5′-methylthioadenosine administration prevents lipid peroxidation and fibrogenesis induced in rat liver by carbon-tetrachloride intoxication
    Simile, MM
    Banni, S
    Angioni, E
    Carta, G
    De Miglio, MR
    Muroni, MR
    Calvisi, DF
    Carru, A
    Pascale, RM
    Feo, F
    JOURNAL OF HEPATOLOGY, 2001, 34 (03) : 386 - 394
  • [9] Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride
    Muriel, P
    Escobar, Y
    JOURNAL OF APPLIED TOXICOLOGY, 2003, 23 (02) : 103 - 108
  • [10] Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE
    Yoshida, Y
    Itoh, N
    Hayakawa, M
    Piga, R
    Cynshi, O
    Jishage, K
    Niki, E
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 208 (01) : 87 - 97